In May, London-based medical technology company LivaNova PLC acquired South Side-based ALung Technologies Inc. for $10 million, with additional payments dependent on sales-based milestones in the future.
ALung is a Pennsylvania-based medical device company that develops and markets extracorporeal carbon dioxide removal devices for patients with acute respiratory distress.